Results 11 to 20 of about 2,400 (204)

A real‐world survey of the diagnostic journey, current treatment, and burden of mild cognitive impairment or dementia due to Alzheimer's disease in China [PDF]

Alzheimers Dement
Abstract Background We aimed to describe the diagnostic journey, current treatment, caregiving needs, and burden of patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia in China. Method Data were drawn from the Adelphi Real World AD Disease Specific Programme™, a cross‐sectional survey of neurologists and their patients ...
Xin J, Zhang H, Cai S, Li J, Dou G, Estrada B, Walker C, Chen X.   +7 more
europepmc   +2 more sources

Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic [PDF]

Evidence-Based Complementary and Alternative Medicine, 2016
Nootropics or smart drugs are well‐known compounds or supplements that enhance the cognitive performance. They work by increasing the mental function such as memory, creativity, motivation, and attention. Recent researches were focused on establishing a new potential nootropic derived from synthetic and natural products.
Noor Azuin Suliman, Che Norma Mat Taib, Mohamad Aris Mohd Moklas, Mohd Ilham Adenan, Mohamad Taufik Hidayat Baharuldin, Rusliza Basir   +5 more
openaire   +3 more sources

Value-Added Products from Ethanol Fermentation—A Review

Fermentation, 2021
Global demand for renewable and sustainable energy is increasing, and one of the most common biofuels is ethanol. Most ethanol is produced by Saccharomyces cerevisiae (yeast) fermentation of either crops rich in sucrose (e.g., sugar cane and sugar beet ...
Timothy J. Tse, Daniel J. Wiens, Farley Chicilo, Sarah K. Purdy, Martin J. T. Reaney   +4 more
doaj   +1 more source

The value of information service for the rational use of nootropics in preferential drug provision

Качественная клиническая практика, 2020
The rational prescription of medicines with preferential drugs provision, including nootropics, which are widely used in patients receiving pharmacotherapy under the «Program for Providing Certain Categories of Citizens with Necessary Drugs», is possible
E. V. Eliseeva, E. S. Maneeva, V. V. Gribova, D. B. Okun   +3 more
doaj   +1 more source

Health and social problems associated with recent Novel Psychoactive Substance (NPS) use amongst marginalised, nightlife and online users in six European countries. [PDF]

, 2017
Continued diversification and use of new psychoactive substances (NPS) across Europe remains a public health challenge. The study describes health and social consequences of recent NPS use as reported in a survey of marginalised, nightlife and online NPS
A Bourne, A Lavorgna, A Lavorgna, AJ Schmidt, Annemieke Benschop, B Moosmann, B Werse, B Werse, Bernd Werse, C Littlejohn, C Soussan, C Soussan, C Soussan, CK Tung, CL Arfken, D Abdulrahim, D Brauser, D Vearrier, D Wood, Dirk Korf, DP Kasick, E Hearne, E Hearne, E Papaseit, EMCDDA, EMCDDA, European Union, Europol-European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Europol-European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Evelyn Hearne, EW Gunderson, F Caudevilla, F Caudevilla, F Measham, F Measham, G Colfax, Gerrit Kamphausen, J Hillebrand, J Rácz, JG Amsterdam van, JK Grandy, Joana Paula Silva, K McElrath, KA Seely, Katalin Felvinczi, Katarzyna Dąbrowska, KJ Lusthof, L Móró, L Orsolini, LA King, LD Johnston, LK Brents, M Pas, M Rosino, M Sande, M Spaderna, M Tzanetakis, Marie Claire Van Hout, MC Hout Van, MC Hout Van, MC Hout Van, MC Hout Van, MC Hout Van, MC Hout Van, MC Hout Van, MC Hout Van, Michal Bujalski, MM Schmidt, NA Bassir, OR Bilgrei, P Reuter, PI Dargan, Psychonaut Web Mapping Research Group, R Csák, RL Carhart-Harris, S Every-Palmer, S Kassai, Susana Henriques, UNODC, V Auwärter, ZN Maan, Zsolt Demetrovics, Zsuzsa Kaló, Łukasz Wieczorek   +83 more
core   +12 more sources

MOLECULAR DESIGN OF N-ACYL DERIVATIVES OF 2-(2-OXOPYROLIDIN-1-YL)-ACETAMIDE WITH GABA-ERGIC AND GLUTAMATERGIC ACTIVITIES

Фармация и фармакология (Пятигорск), 2021
The first of the most successfully implemented nootropic drugs in medical practice is piracetam, which should be attributed to cyclic derivatives of gamma-aminobutyric acid.
I. P. Kodonidi, A. S. Chiriapkin, D. E. Tworowski   +2 more
doaj   +1 more source

Cognitive Enhancement: Treating or Cheating? [PDF]

, 2015
In this article I provide an overview of the moral and medical questions surrounding the use of cognitive enhancers. This discussion will be framed in light of 4 key considerations: (1) is there a difference between therapy and enhancement?
Whetstine, Leslie M.
core   +1 more source

Cerebroprotective prevention of memory disorders using sodium valproate

Zaporožskij Medicinskij Žurnal, 2013
Epilepsy is the disease resulting in impaired cognitive function. The paper deals with the use of nootropics against the background of an anticonvulsant effect.
A. V. Ivanov
doaj   +1 more source

16S rRNA gene profiling and genome reconstruction reveal community metabolic interactions and prebiotic potential of medicinal herbs used in neurodegenerative disease and as nootropics. [PDF]

, 2019
The prebiotic potential of nervine herbal medicines has been scarcely studied. We therefore used anaerobic human fecal cultivation to investigate whether medicinal herbs commonly used as treatment in neurological health and disease in Ayurveda and other ...
Albayrak, Levent, Chopra, Deepak, Fofanov, Yuriy, Iablokov, Stanislav N, Khanipov, Kamil, Mills, Paul J, Peterson, Christine Tara, Peterson, Scott N, Rodionov, Dmitry A, Sharma, Vandana, Uchitel, Sasha   +10 more
core   +5 more sources

Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges

Frontiers in Psychiatry, 2020
Cognitive enhancement, a rather broad-ranging principle, can be achieved in various ways: healthy eating and consistent physical exercise can lead to long-term improvements in many cognitive domains; commonplace stimulants such as caffeine, on the other ...
Giovanna Ricci
doaj   +1 more source